TGFB1 and neoplasm: Results from an in vivo HCC model where HCC cells were co-injected with myofibroblasts, and from an in vitro model with a micro-organoid HCC, suggested that the hepatic tumor-stroma crosstalk promotes tumor growth and EMT through a TGF-β and PDGF signaling axis [167].